Breaking News on Contract Research, Manufacturing & Clinical Trials

CRO Pharmaron and MSD reach shared site agreement

27-Sep-2016 - Pharmaron has acquired MSD’s Hoddesdon, UK-based Good Manufacturing Practice (GMP) standard facilities to advance its API and formulation development.

News in brief

Alcami enhances analytical services in Edison, NJ

27-Sep-2016 - The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

Colorcon and Dow extend controlled release alliance

22-Sep-2016 - Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.

IDT Biologika: trends and demand in first year of US-based contract manufacturing operations

22-Sep-2016 - In its first year of operations, IDT Biologika’s contract manufacturing facility in Rockville, Maryland has experienced rapid growth, which it expects to continue as construction carries on.


Almac: investment to ensure space, staff, larger US footprint

21-Sep-2016 - Yesterday, Almac Group announced a $5.2m investment in its US-based operations, which its global VP of operations said will support customers “across the drug development lifecycle.”

Almac Group announces $5.2m expansion

20-Sep-2016 - In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.

News in brief

CDMO Custom Pharma Services expands operations

20-Sep-2016 - The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.


Promising Korea? CMO giant Samsung Biologics opens doors to Biopharma-Reporter

16-Sep-2016 - Since 2011, Samsung Biologics has built two plants, gained Bristol-Myers Squibb and Roche as clients and launched an IPO. With a third facility under construction, Biopharma-Reporter visited to see the...

Lonza licenses rights to sell synthetic AAVs to gene therapy developers

14-Sep-2016 - Lonza has licensed rights to synthetic adeno-associated viral (AAV) vectors developed by scientists at US hearing research centre, Massachusetts Eye and Ear.

Catalent to plug bioavailability tech gap with Pharmatek Laboratories buy

13-Sep-2016 - Catalent has announced its intention to buy Pharmatek Laboratories to boost its drug bioavailability offering.

AGC leaps into microbial CMO space through Biomeva acquisition

13-Sep-2016 - Japanese glass solution provider AGC Asahi Glass has bought Germany’s Biomeva in a bid to launch itself into the international microbial CMO space.

Avid to construct third plant with two 1,000L single-use bioreactors

13-Sep-2016 - Avid Bioservices will construct a clinical manufacturing plant later this year just months after production began at a second facility.

LI-COR expansion offers early-phase cGMP services

12-Sep-2016 - LI-COR Biosciences has expanded its production facility to offer contract manufacturing for early-phase cGMP materials.

Spain's Idifarma bolstered by investment from API maker Suanfarma

12-Sep-2016 - Spanish API maker Suanfarma has acquired a stake in contract manufacturer and spray-drying specialist Idifarma, boosting its international presence.

Cambrex investment continues as industry trends ‘remain favorable’

07-Sep-2016 - The latest in a series of investments, Cambrex has recently expanded its Sweden-based site as part of its ongoing investment in small molecule API manufacturing across its global network of...

AMRI expects to make layoffs during Euticals integration

07-Sep-2016 - AMRI has said integrating recent Italian acquisition Prime European Therapeuticals, also known as Euticals, will involve layoffs.

More Cambrex capacity expansion: API firm to grow Karlskoga facility

07-Sep-2016 - Cambrex will spend $9m (€8m) to add large-scale manufacturing capability at its API production facility in Karlskoga, Sweden.

Brexit revisited: focusing on 'the war on talent'

06-Sep-2016 - More than two months after Britain decided to leave the EU, companies reevaluate the state of business and what comes next, specifically for jobs within the industry.

SGS opens dedicated extractables and leachables testing facility

06-Sep-2016 - SGS has opened a new Wiesbaden-based facility to serve as its global Center of Excellence for Extractable Studies and Impurities Profiling as customer demand increases.

Vibalogics expands German fill/finish site on back of clinical demand

02-Sep-2016 - German CDMO Vibalogics has upped its capabilities 300% citing a lack of worldwide capacity for biologics fill and finish.

Needle-free tech company partners with WHO as part of polio eradication effort

01-Sep-2016 - PharmaJet has inked a multi-year deal with the World Health Organization for its needle-free technology, which uses 80% less vaccine than traditional methods.  

Recipharm inks manufacturing and controlled release tech deal with Tillotts

01-Sep-2016 - Recipharma will provide pellet coating technology for controlled release drugs to Tillotts Pharma as part of a long-term manufacturing deal.

Hikma continues beefing up US and European manufacturing capabilities

29-Aug-2016 - Hikma invested over $25m in its US facilities in the first half 2016, and plans to use excess capacity at a former Boehringer Ingelheim plant for contract manufacturing.

API firm Unimark Remedies warned by US FDA about Indian plants

25-Aug-2016 - The US FDA has warned API manufacturer Unimark Remedies about unsanitary conditions at its facility in Vapi and Bavla in India.

CMO contracts will transfer to Pfizer

Pfizer to buy AstraZeneca's antibiotic business in deal worth up to $1.5bn

24-Aug-2016 - Pfizer will buy most of AstraZeneca’s antibiotics business in a $1.5bn (€1.32bn) deal that will see the Anglo-Swedish drug firm continue to package Merrem at its Macclesfield, UK plant for at least the next...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...